Novartis: Attention Deficit Disorder with Hyperactivity trials
The registry lists 10 Attention Deficit Disorder with Hyperactivity studies with Novartis as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 2 1Phase 3 7Phase 4 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity DisorderCompletedNCT01338818Phase 3Results posted
- Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT01259492Phase 3Results posted
- Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.CompletedNCT00776009Phase 4Results posted
- A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00564954Phase 4Results posted
- Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)CompletedNCT00428792Phase 3Results posted
- Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00409708Phase 2Results posted
- Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity DisorderCompletedNCT00301236Phase 3
- Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14CompletedNCT00254878Phase 3
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedNCT00141063Phase 3
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedNCT00141050Phase 3